DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, today announced new data showing expanded hemodialysis, known as HDx ...
Baxter International Inc. BAX recently showcased THERANOVA, a new class of medium cut-off (MCO) dialysers at the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA) ...
Baxter’s HDx therapy enabled by THERANOVA was designed to filter a wider range of molecules from the blood than conventional hemodialysis filters, including mid-sized molecular weight uremic toxins ...
Baxter International Inc. BAX recently announced favorable data from the “Effectiveness of medium cut-off versus high flux dialyzers: An inverse probability weighting cohort study”. The data ...
(RTTNews) - Baxter International Inc. (BAX) announced enrollment of first patients in two new clinical trials for a unique expanded hemodialysis or HDx therapy enabled by THERANOVA. The U.S. trial is ...
"The introduction of HDx enabled by THERANOVA provides an opportunity for Canadian healthcare providers to offer a new treatment option to their hemodialysis patients that is easy to perform and may ...
Baxter International Inc. BAX recently announced that its novel dialysis membrane, Theranova has been granted the FDA De Novo application. Notably, Theranova was developed to deliver expanded ...
Please provide your email address to receive an email when new articles are posted on . Baxter International Inc. highlighted new data from two studies presented at ...
Baxter International Inc. has scored a win from the U.S. FDA, which has granted the de novo application for Theranova, the company’s novel dialysis membrane. For his part, Cowen’s Josh Jennings noted ...
Baxter International Inc.BAX recently showcased THERANOVA, a new class of medium cut-off (MCO) dialysers at the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA) ...
Baxter International Inc. BAX recently announced favorable data from the “Effectiveness of medium cut-off versus high flux dialyzers: An inverse probability weighting cohort study”. The data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results